DGS Capital Management LLC Takes $377,000 Position in DocuSign, Inc. (NASDAQ:DOCU)

DGS Capital Management LLC bought a new position in shares of DocuSign, Inc. (NASDAQ:DOCU) in the fourth quarter, HoldingsChannel reports. The firm bought 4,192 shares of the company’s stock, valued at approximately $377,000.

Several other institutional investors also recently bought and sold shares of DOCU. Avior Wealth Management LLC grew its holdings in shares of DocuSign by 36.5% in the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares in the last quarter. J.W. Cole Advisors Inc. lifted its position in DocuSign by 2.0% during the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock valued at $493,000 after purchasing an additional 155 shares during the last quarter. Resonant Capital Advisors LLC grew its stake in shares of DocuSign by 0.9% in the 3rd quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock worth $1,088,000 after buying an additional 157 shares in the last quarter. Optimist Retirement Group LLC increased its holdings in shares of DocuSign by 3.8% in the 3rd quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after buying an additional 161 shares during the last quarter. Finally, V Square Quantitative Management LLC raised its position in shares of DocuSign by 6.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock valued at $187,000 after buying an additional 172 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

DocuSign Price Performance

Shares of DOCU opened at $91.60 on Friday. The firm has a market capitalization of $18.51 billion, a price-to-earnings ratio of 18.89, a PEG ratio of 8.30 and a beta of 0.88. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The company has a 50-day moving average of $89.76 and a 200 day moving average of $71.43.

Insider Transactions at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,764 shares of the firm’s stock in a transaction on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the transaction, the chief executive officer now directly owns 107,825 shares in the company, valued at $7,542,358.75. This trade represents a 6.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Peter Solvik sold 10,000 shares of the company’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $91.26, for a total value of $912,600.00. Following the completion of the sale, the director now owns 150,253 shares of the company’s stock, valued at $13,712,088.78. This represents a 6.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 693,537 shares of company stock valued at $66,575,817. 1.66% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Royal Bank of Canada reissued a “sector perform” rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a research report on Friday, December 6th. Citigroup raised their price target on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Wells Fargo & Company boosted their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research report on Friday, December 6th. Finally, Jefferies Financial Group raised their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $92.45.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.